Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
GENERTEC UNIVERSAL MEDICAL GROUP COMPANY
LIMITED
通用環球醫療集團有限公司
(Incorporated in Hong Kong with limited liability)
(Stock Code：2666)
RESIGNATION OF NON-EXECUTIVE DIRECTORS
AND
CHANGES IN COMPOSITION OF THE AUDIT COMMITTEE AND THE
RISK CONTROL COMMITTEE
The Board announces that with effect from 6 March 2021:
(i) Mr. Liu Xiaoping resigned as a non-executive Director and a member of the Audit Committee;
(ii) Mr. Su Guang resigned as a non-executive Director and the chairman of the Risk Control
Committee; and
(iii) there are changes in composition of members of each of the Risk Control Committee and Audit Committee.
RESIGNATION OF NON-EXECUTIVE DIRECTORS
The board (the "Board") of directors (the "Directors", and each a "Director") of Genertec Universal Medical Group Company Limited (the "Company") announces that it received theresignation letters from Mr. Liu Xiaoping ("Mr. Liu") and Mr. Su Guang ("Mr. Su"), two non-executive Directors. Upon the expiration of their current terms of office as Directors and with effect from 6 March 2021, (i) Mr. Liu resigned as a non-executive Director and a member of the Board's audit committee (the "Audit Committee"), due to his other work arrangements; and (ii) Mr. Su resigned as a non-executive Director and the chairman of the Board's risk control committee (the "Risk Control Committee"), due to his other work arrangements.
Each of Mr. Liu and Mr. Su has confirmed that he has no disagreement with the Board, and he is not aware of other matters in connection with his resignation that need to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited (the "Stock Exchange").
The Board would like to express its sincere gratitude to Mr. Liu and Mr. Su for their valuable contributions to the Company during their respective tenure.
CHANGES IN THE COMPOSITION OF THE AUDIT COMMITTEE AND THE RISK CONTROL COMMITTEE
The Board would like to announce that with effect from 6 March 2021, (i) Mr. Liu ceased to be a member of the Audit Committee, and (ii) Mr. Su ceased to be the chairman of the Risk Control Committee.
Upon Mr. Liu's resignation, the Audit Committee comprises the following Directors:
Mr. Li Yinquan (chairman of the committee and independent non-executive Director)
Mr. Chow Siu Lui (independent non-executive Director)
Upon Mr. Su's resignation, the Risk Control Committee comprises the following Directors:
Mr. Liu Zhiyong (non-executive Director)
Ms. Peng Jiahong (executive Director)
Accordingly, (i) the number of members of the Audit Committee will fall below the minimum number required under Rule 3.21 of the Rules Governing the Listing of Securities on the Stock Exchange (the "Listing Rules") and Article 2.1 of the terms of reference of the Audit Committee; and (ii) the number of members of the Risk Control Committee will fall below the minimum number required under Article 2.1 of the terms of reference of the Risk Control Committee.
The Company will identify suitable candidates to fill the above vacancies in the Audit Committee and the Risk Control Committee within three months from 6 March 2021 to comply with the requirements under the Listing Rules and the relevant terms of reference. Further announcement(s) will be made by the Company as and when appropriate.
By order of the Board
Genertec Universal Medical Group Company
Limited 通用環球醫療集團有限公司
Peng Jiahong Executive Director
Beijing, PRC, 8 March 2021
As at the date of this announcement, the executive Directors are Ms. Peng Jiahong (Vice-chairwoman) and Mr. Yu Gang; the non-executive Directors are Mr. Zhang Yichen (Chairman), Ms. Liu Kun and Mr. Liu Zhiyong; and the independent non-executive Directors are Mr. Li Yinquan, Mr. Chow Siu Lui, Mr. Han Demin and Mr. Liao Xinbo.